tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Tenaya Therapeutics announces orderly board leadership transition
PremiumCompany AnnouncementsTenaya Therapeutics announces orderly board leadership transition
1M ago
Tenaya Therapeutics price target lowered to $4 from $6 at Canaccord
Premium
The Fly
Tenaya Therapeutics price target lowered to $4 from $6 at Canaccord
2M ago
Promising Initial Data and Safety Profile Justify Buy Rating for Tenaya Therapeutics’ TN-401
Premium
Ratings
Promising Initial Data and Safety Profile Justify Buy Rating for Tenaya Therapeutics’ TN-401
2M ago
Tenaya Therapeutics price target lowered to $8 from $9 at Chardan
PremiumThe FlyTenaya Therapeutics price target lowered to $8 from $9 at Chardan
2M ago
Tenaya Therapeutics 50M share Spot Secondary priced at $1.20
Premium
The Fly
Tenaya Therapeutics 50M share Spot Secondary priced at $1.20
2M ago
FDA Lifts Hold on Tenaya’s MyPEAK-1 Trial
Premium
Company Announcements
FDA Lifts Hold on Tenaya’s MyPEAK-1 Trial
2M ago
Promising Outlook for Tenaya Therapeutics’ TN-201 Program Despite Procedural Clinical Hold
PremiumRatingsPromising Outlook for Tenaya Therapeutics’ TN-201 Program Despite Procedural Clinical Hold
3M ago
Tenaya Therapeutics reports Q3 EPS (12c), consensus (15c)
Premium
The Fly
Tenaya Therapeutics reports Q3 EPS (12c), consensus (15c)
3M ago
Promising Clinical Developments and Regulatory Optimism Drive Buy Rating for Tenaya Therapeutics
Premium
Ratings
Promising Clinical Developments and Regulatory Optimism Drive Buy Rating for Tenaya Therapeutics
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100